Terms: = Breast cancer AND TFRC, P02786, 7037, ENSG00000072274, TFR1, CD71 AND Prognosis
14 results:
1. Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis.
Zhou T; Xie Y; Hou X; Bai W; Li X; Liu Z; Man Q; Sun J; Fu D; Yan J; Zhang Z; Wang Y; Wang H; Jiang W; Gao S; Zhao T; Chang A; Wang X; Sun H; Zhang X; Yang S; Huang C; Hao J; Liu J
J Exp Clin Cancer Res; 2023 May; 42(1):111. PubMed ID: 37143164
[TBL] [Abstract] [Full Text] [Related]
2. A Novel Immune-Related Signature to Predict prognosis and Immune Infiltration of Cervical cancer.
Lin Y; Zhang R; Pan H; Li Y
Med Sci Monit; 2023 Mar; 29():e938660. PubMed ID: 36973995
[TBL] [Abstract] [Full Text] [Related]
3. Biomarker Profiling Revealed Carcinoembryonic Antigen as a Target of Artesunate in a Ductal breast cancer Patient.
Saeed MEM; Drif AI; Efferth T
Anticancer Res; 2022 Jul; 42(7):3483-3494. PubMed ID: 35790273
[TBL] [Abstract] [Full Text] [Related]
4. Integrated analysis identifies tfr1 as a prognostic biomarker which correlates with immune infiltration in breast cancer.
Chen F; Fan Y; Hou J; Liu B; Zhang B; Shang Y; Chang Y; Cao P; Tan K
Aging (Albany NY); 2021 Sep; 13(17):21671-21699. PubMed ID: 34518441
[TBL] [Abstract] [Full Text] [Related]
5. Quantitative Analysis of Transferrin Receptor 1 (tfr1) in Individual breast cancer Cells by Means of Labeled Antibodies and Elemental (ICP-MS) Detection.
Corte-Rodríguez M; Blanco-González E; Bettmer J; Montes-Bayón M
Anal Chem; 2019 Dec; 91(24):15532-15538. PubMed ID: 31694367
[TBL] [Abstract] [Full Text] [Related]
6. Copy number profiling of Oncotype DX genes reveals association with survival of breast cancer patients.
Ahmed W; Malik MFA; Saeed M; Haq F
Mol Biol Rep; 2018 Dec; 45(6):2185-2192. PubMed ID: 30225582
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic significance of androgen receptor expression in invasive breast cancer: transcriptomic and protein expression analysis.
Aleskandarany MA; Abduljabbar R; Ashankyty I; Elmouna A; Jerjees D; Ali S; Buluwela L; Diez-Rodriguez M; Caldas C; Green AR; Ellis IO; Rakha EA
Breast Cancer Res Treat; 2016 Sep; 159(2):215-27. PubMed ID: 27514395
[TBL] [Abstract] [Full Text] [Related]
8. Local iron homeostasis in the breast ductal carcinoma microenvironment.
Marques O; Porto G; Rêma A; Faria F; Cruz Paula A; Gomez-Lazaro M; Silva P; Martins da Silva B; Lopes C
BMC Cancer; 2016 Mar; 16():187. PubMed ID: 26944411
[TBL] [Abstract] [Full Text] [Related]
9. Clinical and biological significance of glucocorticoid receptor (GR) expression in breast cancer.
Abduljabbar R; Negm OH; Lai CF; Jerjees DA; Al-Kaabi M; Hamed MR; Tighe PJ; Buluwela L; Mukherjee A; Green AR; Ali S; Rakha EA; Ellis IO
Breast Cancer Res Treat; 2015 Apr; 150(2):335-46. PubMed ID: 25762479
[TBL] [Abstract] [Full Text] [Related]
10. Tissue-specific selection of optimal reference genes for expression analysis of anti-cancer drug-related genes in tumor samples using quantitative real-time RT-PCR.
Wang H; Yang B; Geng T; Li B; Dai P; Chen C
Exp Mol Pathol; 2015 Jun; 98(3):375-81. PubMed ID: 25445497
[TBL] [Abstract] [Full Text] [Related]
11. The oestrogen receptor coactivator CARM1 has an oncogenic effect and is associated with poor prognosis in breast cancer.
Habashy HO; Rakha EA; Ellis IO; Powe DG
Breast Cancer Res Treat; 2013 Jul; 140(2):307-16. PubMed ID: 23887673
[TBL] [Abstract] [Full Text] [Related]
12. An iron regulatory gene signature predicts outcome in breast cancer.
Miller LD; Coffman LG; Chou JW; Black MA; Bergh J; D'Agostino R; Torti SV; Torti FM
Cancer Res; 2011 Nov; 71(21):6728-37. PubMed ID: 21875943
[TBL] [Abstract] [Full Text] [Related]
13. Transferrin receptor (cd71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen.
Habashy HO; Powe DG; Staka CM; Rakha EA; Ball G; Green AR; Aleskandarany M; Paish EC; Douglas Macmillan R; Nicholson RI; Ellis IO; Gee JM
Breast Cancer Res Treat; 2010 Jan; 119(2):283-93. PubMed ID: 19238537
[TBL] [Abstract] [Full Text] [Related]
14. Investigation of genetic variants of genes of the hemochromatosis pathway and their role in breast cancer.
Abraham BK; Justenhoven C; Pesch B; Harth V; Weirich G; Baisch C; Rabstein S; Ko YD; Brüning T; Fischer HP; Haas S; Brod S; Oberkanins C; Hamann U; Brauch H;
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1102-7. PubMed ID: 15894659
[TBL] [Abstract] [Full Text] [Related]
